- What is FineTech Pharmaceutical's primary business?
- FineTech Pharmaceutical develops and manufactures active pharmaceutical ingredients (APIs) with the goal of bypassing process and polymorph patents. The company also offers analytical method development and patent analysis.
- When was FineTech Pharmaceutical founded?
- FineTech Pharmaceutical was founded in January 1990 as FineTech Laboratories Ltd in conjunction with the Technion – Israel Institute of Technology.
- What is the current status of FineTech Pharmaceutical?
- FineTech Pharmaceutical was acquired by OPKO Health in December 2011.
- What types of APIs does FineTech Pharmaceutical specialize in?
- FineTech Pharmaceutical's APIs include Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride. The company specializes in organic processes, including multi-step synthesis, polymorph development, chromatography, and chiral and prostaglandin chemistry.
- How many employees does FineTech Pharmaceutical have?
- FineTech Pharmaceutical has an employee count in the 11-50 range.
- Where is FineTech Pharmaceutical headquartered?
- FineTech Pharmaceutical is headquartered in Nesher, North District, Israel.
- What certifications or standards does FineTech Pharmaceutical adhere to?
- FineTech Pharmaceutical operates in an FDA-registered facility and abides by cGMP standards.
- Does FineTech Pharmaceutical hold any patents?
- Yes, FineTech Pharmaceutical has patents.
